We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study.
- Authors
Winkler, Karl; Konrad, Thomas; Füllert, Stefanie; Friedrich, Isolde; Destani, Ramadan; Baumstark, Manfred W; Krebs, Kristin; Wieland, Heinrich; März, Winfried
- Abstract
The oral antidiabetic agent pioglitazone improves insulin sensitivity and glycemic control and appears to lower atherogenic dense LDL in type 2 diabetes. Insulin resistance may occur frequently in nondiabetic patients with hypertension. This study is the first to report the effect of pioglitazone on LDL subfractions in normolipidemic, nondiabetic patients with arterial hypertension.
- Publication
Diabetes care, 2003, Vol 26, Issue 9, p2588
- ISSN
0149-5992
- Publication type
Journal Article
- DOI
10.2337/diacare.26.9.2588